Christopher Missling
Chief Executive Officer at ANAVEX LIFE SCIENCES CORP.
Net worth: 4 M $ as of 2024-04-29
Christopher Missling active positions
Companies | Position | Start | End |
---|---|---|---|
ANAVEX LIFE SCIENCES CORP. | Director/Board Member | - | - |
Chief Executive Officer | 2013-07-04 | - | |
President | 2013-07-04 | - | |
Corporate Secretary | 2013-07-04 | - | |
Chairman | - | - | |
Director of Finance/CFO | 2013-07-04 | 2015-09-30 | |
Investor Relations Contact | 2013-07-04 | - | |
Treasurer | 2013-07-04 | - |
Career history of Christopher Missling
Former positions of Christopher Missling
Companies | Position | Start | End |
---|---|---|---|
Aventis, Inc. | Corporate Officer/Principal | - | - |
IMMUNOGEN, INC. | Director of Finance/CFO | - | - |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Brimberg & Co. LP is a broker/dealer headquartered in New York City. They provide a full array of trading and execution services for their clients. They do not provide any internal research. | Corporate Officer/Principal | - | - |
CURIS, INC. | Director of Finance/CFO | - | - |
Training of Christopher Missling
Ludwig-Maximilians-Universität München | Doctorate Degree |
Kellogg School of Management | Masters Business Admin |
WHU-Otto Beisheim School of Management | Masters Business Admin |
Statistics
International
United States | 7 |
Germany | 3 |
Operational
Director of Finance/CFO | 3 |
Masters Business Admin | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CURIS, INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
ANAVEX LIFE SCIENCES CORP. | Health Technology |
Private companies | 2 |
---|---|
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Brimberg & Co. LP is a broker/dealer headquartered in New York City. They provide a full array of trading and execution services for their clients. They do not provide any internal research. | Finance |
Aventis, Inc. |
- Stock Market
- Insiders
- Christopher Missling
- Experience